Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 3Polyps 1Lymphoma, Follicular 1Liver Neoplasms 1Huntington Disease 1Carcinoma, Non-Small-Cell Lung 1Adenomatous Polyposis Coli 1

Interventions

guselkumab 2Sulindac 2Eflornithine 2Celecoxib 2trifluridine tipiracil drug combination 1rofecoxib 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Endoscopy 1Eicosapentaenoic Acid 1Duration of Therapy 1Docosahexaenoic Acids 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Adenomatous Polyposis Coli × Docosahexaenoic Acids × Clear all
NCT03806426 2024-04-25

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

S.L.A. Pharma AG

Phase 3 Unknown
204 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡